Supplementary Materials
Supplementary Material for:
Evaluating Preclinical Efficacy
Mark A. Atkinson*
*To whom correspondence should be addressed. E-mail: atkinson{at}ufl.edu
Published 17 August 2011, Sci. Transl. Med. 3, 96cm22 (2011)
DOI: 10.1126/scitranslmed.3002757
Supplementary Material for this manuscript includes the following:
Table S1. Attempts to reverse Type 1 diabetes in NOD mice between 1990 and 2010. An influence of human study results on the design of experiments in mice.
